Nov 29, 2017· Comment from Association for Accessible Medicines· FDA-2017-D-5525-0012
Comments from The Association for Accessible Medicines (AAM) and Biosimilars Council regarding Docket FDA-2017-D-5525: Draft Guidance on Statistical Approaches to Evaluate Analytical Similarity.